$DWAY
Driveitaway Holdings, Inc. Stock $dway

$dway Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000173112222001512 Filed on September 07, 2022

Income Statement

Concept	2022 Q2	2021 Q2
Revenue	$7.084K	$462.6K
YoY Change	-98.47%	-25.59%
Cost Of Revenue	$10.69K	$59.25K
YoY Change	-81.95%	-21.64%
Gross Profit	-$3.610K	$403.4K
YoY Change	-100.89%	-26.13%
Gross Profit Margin	-50.96%	87.19%
Selling, General & Admin	$34.12K	$496.2K
YoY Change	-93.12%	-5.04%
% of Gross Profit		123.01%
Research & Development	$16.44K	$18.87K
YoY Change	-12.86%
% of Gross Profit		4.68%
Depreciation & Amortization	$4.650K	$31.25K
YoY Change	-85.12%	18.91%
% of Gross Profit		7.75%
Operating Expenses	$330.5K	$527.4K
YoY Change	-37.33%	-3.89%
Operating Profit	-$334.2K	-$124.1K
YoY Change	169.37%	4494.44%
Interest Expense	$20.03K	$3.752K
YoY Change	433.85%
% of Operating Profit
Other Income/Expense, Net	-$308.2K	$710.00
YoY Change	-43509.15%	-224.56%
Pretax Income	-$642.4K	-$123.3K
YoY Change	420.8%	3671.87%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$642.4K	-$123.3K
YoY Change	420.8%	3671.87%
Net Earnings / Revenue	-9067.74%	-26.66%
Basic Earnings Per Share	-$0.01
Diluted Earnings Per Share	-$7.372K	-$9.315K
COMMON SHARES
Basic Shares Outstanding	87.14M shares
Diluted Shares Outstanding	87.14M shares

Balance Sheet

Concept	2022 Q2	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$389.7K	$380.4K
YoY Change	2.43%	-22.57%
Cash & Equivalents	$389.7K	$78.80K
Short-Term Investments
Other Short-Term Assets		$198.2K
YoY Change		-40.35%
Inventory
Prepaid Expenses
Receivables	$6.096K	$199.5K
Other Receivables	$0.00	$6.680K
Total Short-Term Assets	$395.8K	$784.7K
YoY Change	-49.57%	-39.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$121.8K	$48.76K
YoY Change	149.71%	-70.1%
Goodwill	$1.557M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$318.4K
YoY Change		-47.11%
Total Long-Term Assets	$1.679M	$367.2K
YoY Change	357.26%	-52.01%
TOTAL ASSETS
Total Short-Term Assets	$395.8K	$784.7K
Total Long-Term Assets	$1.679M	$367.2K
Total Assets	$2.075M	$1.152M
YoY Change	80.11%	-43.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$109.2K	$294.3K
YoY Change	-62.9%	292.65%
Accrued Expenses	$16.71K	$22.59K
YoY Change	-26.03%	-32.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$120.0K
YoY Change	-100.0%	0.0%
Long-Term Debt Due	$623.4K
YoY Change
Total Short-Term Liabilities	$750.0K	$1.183M
YoY Change	-36.6%	-1.54%
LONG-TERM LIABILITIES
Long-Term Debt	$805.8K	$0.00
YoY Change
Other Long-Term Liabilities		$1.475M
YoY Change		-46.19%
Total Long-Term Liabilities	$805.8K	$1.475M
YoY Change	-45.35%	-46.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$750.0K	$1.183M
Total Long-Term Liabilities	$805.8K	$1.475M
Total Liabilities	$1.096M	$2.658M
YoY Change	-58.77%	-32.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.641M
YoY Change
Common Stock	$3.177M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	15.10K shares
Shareholders Equity	$518.8K	-$422.1K
YoY Change
Total Liabilities & Shareholders Equity	$2.075M	$1.152M
YoY Change	80.11%	-43.99%

Cashflow Statement

Concept	2022 Q2	2021 Q2
OPERATING ACTIVITIES
Net Income	-$642.4K	-$123.3K
YoY Change	420.8%	3671.87%
Depreciation, Depletion And Amortization	$4.650K	$31.25K
YoY Change	-85.12%	18.91%
Cash From Operating Activities	-$327.0K	-$19.34K
YoY Change	1590.74%	-90.91%
INVESTING ACTIVITIES
Capital Expenditures	-$126.4K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$820.00
YoY Change	-100.0%	0.0%
Cash From Investing Activities	-$126.4K	$830.00
YoY Change	-15330.12%	1.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	250.0K	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-327.0K	-19.34K
Cash From Investing Activities	-126.4K	830.0
Cash From Financing Activities	250.0K	0.000
Net Change In Cash	-203.4K	-18.51K
YoY Change	998.87%	-79.87%
FREE CASH FLOW
Cash From Operating Activities	-$327.0K	-$19.34K
Capital Expenditures	-$126.4K	$0.00
Free Cash Flow	-$200.6K	-$19.34K
YoY Change	937.13%	-90.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	clcn	Loss On Contingency Libility LossOnContingencyLibility		usd
CY2022Q2	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness		usd
CY2021Q2	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness		usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness		usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2021Q2	clcn	Basic And Diluted Weighted Average Number Of Common Shares Outstanding BasicAndDilutedWeightedAverageNumberOfCommonSharesOutstanding		shares
	clcn	Basic And Diluted Weighted Average Number Of Common Shares Outstanding BasicAndDilutedWeightedAverageNumberOfCommonSharesOutstanding		shares
CY2021Q2	clcn	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare
	clcn	Proceeds From Sba Loan ProceedsFromSbaLoan		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001394638
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q3	us-gaap	Goodwill Goodwill		usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q2	clcn	Ppp Loan PppLoan		usd
CY2022Q2	clcn	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties		usd
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2022Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent		usd
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue		usd
CY2021Q2	clcn	Loss On Contingency Libility LossOnContingencyLibility		usd
CY2022Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
	clcn	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare
CY2022Q2	clcn	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock		usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness		usd
	clcn	Loss On Contingency Liability LossOnContingencyLiability		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	clcn	Acquisition Of Subsidiary AcquisitionOfSubsidiary		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest		usd
	clcn	Preferred Stock Issued For Conversion Of Debt Related Parties PreferredStockIssuedForConversionOfDebtRelatedParties		usd
	clcn	Preferred Stock Issued For Conversion Of Debt PreferredStockIssuedForConversionOfDebt		usd
	clcn	Common Stock And Warrant Issued In Connection With Promissory Note CommonStockAndWarrantIssuedInConnectionWithPromissoryNote		usd
	clcn	Debt Discount Recorded For Warrants Issued In Connections With Convertible Notes DebtDiscountRecordedForWarrantsIssuedInConnectionsWithConvertibleNotes		usd
	clcn	Conversion Preferred Stock To Common Stock ConversionPreferredStockToCommonStock		usd
	clcn	Cancellations Of Common Shares Against Note Receivable CancellationsOfCommonSharesAgainstNoteReceivable		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-52883
	dei	Entity Registrant Name EntityRegistrantName	DRIVEITAWAY HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4456503
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3401 Market Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200/201
	dei	Entity Address City Or Town EntityAddressCityOrTown	Philadelphia
	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19104
	dei	City Area Code CityAreaCode	(856)
	dei	Local Phone Number LocalPhoneNumber	577-2763
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	105286622	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	389664	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9774	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6096	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21455	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	395760	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	31229	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1557106	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4645	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4645	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	121761	usd
CY2022Q2	us-gaap	Assets Assets	2074627	usd
CY2021Q3	us-gaap	Assets Assets	31229	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	109187	usd
CY2021Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	132696	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16710	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29386	usd
CY2022Q2	srt	Bank Loans BankLoans	11183	usd
CY2021Q3	srt	Bank Loans BankLoans	6128	usd
CY2021Q3	clcn	Ppp Loan PppLoan	23750	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	726	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	7268	usd
CY2021Q3	clcn	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	30000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	612212	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	750018	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	229228	usd
CY2022Q2	clcn	Sba Loan Noncurrent SbaLoanNoncurrent	103517	usd
CY2021Q3	clcn	Sba Loan Noncurrent SbaLoanNoncurrent	72372	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	242296	usd
CY2021Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	150000	usd
CY2021Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	65000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1095831	usd
CY2021Q3	us-gaap	Liabilities Liabilities	516600	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	460000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2300000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2300000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2300000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2300000	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	230	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105301722	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105286622	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	10531	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3166951	usd
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	419793	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	15100	shares
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	18126	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2640560	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-905394	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	518796	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-485371	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2074627	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31229	usd
CY2022Q2	us-gaap	Revenues Revenues	7084	usd
CY2021Q2	us-gaap	Revenues Revenues	31835	usd
	us-gaap	Revenues Revenues	28730	usd
	us-gaap	Revenues Revenues	93200	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10694	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9859	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21789	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30214	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-3610	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	21976	usd
	us-gaap	Gross Profit GrossProfit	6941	usd
	us-gaap	Gross Profit GrossProfit	62986	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	104525	usd
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	46500	usd
	us-gaap	Salaries And Wages SalariesAndWages	294600	usd
	us-gaap	Salaries And Wages SalariesAndWages	147551	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	175460	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	173077	usd
	us-gaap	Professional Fees ProfessionalFees	541857	usd
	us-gaap	Professional Fees ProfessionalFees	231554	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24851	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13331	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54697	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44570	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16442	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18868	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45827	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	66540	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	9266	usd
CY2021Q2	us-gaap	Selling Expense SellingExpense	432	usd
	us-gaap	Selling Expense SellingExpense	14155	usd
	us-gaap	Selling Expense SellingExpense	2812	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	330544	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	252208	usd
	us-gaap	Operating Expenses OperatingExpenses	951136	usd
	us-gaap	Operating Expenses OperatingExpenses	493027	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-334154	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-230232	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-944195	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-430041	usd
CY2022Q2	clcn	Loss On Contingency Libility LossOnContingencyLibility	60000	usd
	clcn	Loss On Contingency Libility LossOnContingencyLibility	460000	usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness	-24148	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	228182	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	315865	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	20030	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	3752	usd
	us-gaap	Interest Expense InterestExpense	36970	usd
	us-gaap	Interest Expense InterestExpense	5338	usd
CY2021Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	1421	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	2296	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	3943	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	7	usd
	us-gaap	Interest Income Other InterestIncomeOther	12	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-308205	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5173	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-790971	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9281	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-642359	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-235405	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1735166	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-439322	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-642359	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-235405	usd
	us-gaap	Profit Loss ProfitLoss	-1735166	usd
	us-gaap	Profit Loss ProfitLoss	-439322	usd
CY2022Q2	clcn	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.01
	clcn	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.06
CY2022Q2	clcn	Basic And Diluted Weighted Average Number Of Common Shares Outstanding BasicAndDilutedWeightedAverageNumberOfCommonSharesOutstanding	87135481	shares
	clcn	Basic And Diluted Weighted Average Number Of Common Shares Outstanding BasicAndDilutedWeightedAverageNumberOfCommonSharesOutstanding	31381342	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-485371	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	173077	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-251721	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-564015	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	115384	usd
CY2022Q1	clcn	Preferred Stock Issued For Conversion Of Debt Related Party PreferredStockIssuedForConversionOfDebtRelatedParty	104564	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	288458	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	84375	usd
CY2022Q1	clcn	Reorganization Reorganization	1720867	usd
CY2022Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	344696	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-841086	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1253243	usd
CY2022Q2	clcn	Cancellation Of Common Shares Against Note Receivable CancellationOfCommonSharesAgainstNoteReceivable	-100000	usd
CY2022Q2	clcn	Debt Discount Recorded For Warrants Issued In Connection With Convertible Notes DebtDiscountRecordedForWarrantsIssuedInConnectionWithConvertibleNotes	7912	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-642359	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	518796	usd
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-219100	usd
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-98759	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-317859	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	57693	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-105158	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-365324	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	173077	usd
CY2021Q2	clcn	Related Party Contributions RelatedPartyContributions	5566	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-235405	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-422086	usd
	us-gaap	Profit Loss ProfitLoss	-1735166	usd
	us-gaap	Profit Loss ProfitLoss	-439322	usd
	clcn	Gain On Ppp Loan Forgiveness GainOnPppLoanForgiveness	-24148	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	372836	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	230770	usd
	us-gaap	Depreciation Depreciation	4645	usd
	clcn	Loss On Contingency Liability LossOnContingencyLiability	460000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	315865	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	3022	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	3943	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15359	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4278	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23508	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2460	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5420	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	32054	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-616515	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-170737	usd
	clcn	Acquisition Of Subsidiary AcquisitionOfSubsidiary	-70361	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126406	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56045	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	65000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1016250	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	150000	usd
	clcn	Proceeds From Sba Loan ProceedsFromSbaLoan	36200	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	5566	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1052450	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	220566	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	379890	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	49829	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9774	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28975	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	389664	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78804	usd
	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest	19792	usd
	clcn	Preferred Stock Issued For Conversion Of Debt Related Parties PreferredStockIssuedForConversionOfDebtRelatedParties	104564	usd
	clcn	Preferred Stock Issued For Conversion Of Debt PreferredStockIssuedForConversionOfDebt	288458	usd
	clcn	Common Stock And Warrant Issued In Connection With Promissory Note CommonStockAndWarrantIssuedInConnectionWithPromissoryNote	344696	usd
	clcn	Debt Discount Recorded For Warrants Issued In Connections With Convertible Notes DebtDiscountRecordedForWarrantsIssuedInConnectionsWithConvertibleNotes	7912	usd
	clcn	Conversion Preferred Stock To Common Stock ConversionPreferredStockToCommonStock	8809	usd
	clcn	Cancellations Of Common Shares Against Note Receivable CancellationsOfCommonSharesAgainstNoteReceivable	100000	usd
	clcn	Number Of Shares Exchaged NumberOfSharesExchaged	2594593	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_84B_eus-gaap--FiscalPeriod_zvJNhPedIvua" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_865_zLIGwA87jvj7">Fiscal year</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates on a September 30 fiscal year-end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zTWSTJSuINLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86B_zChKLY99tB4a">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. The significant estimates and assumptions made by management include allowance for doubtful accounts, allowance for deferred tax assets, fair value of equity instruments. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Cash Cash	389664	usd
CY2021Q3	us-gaap	Cash Cash	9774	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2788571	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	78473908	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zlBEpPgXIQw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_862_zSOicTf4lu3h">Reclassification</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105301722	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	15100	shares
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Preferred Stock Redemption Terms PreferredStockRedemptionTerms	The Series A Preferred Stock is entitled to receive, prior to any distribution to any junior class of securities, an amount equal to $0.01 per share as a liquidation preference before any distribution may be made to the holders of any junior security, including the Common Stock.
	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Each share of Series A Preferred Stock is convertible into 33.94971 shares of Common Stock at the option of the holder thereof.
	us-gaap	Profit Loss ProfitLoss	-1735166	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	616515	usd
	clcn	Increase In Cash From Financings IncreaseInCashFromFinancings	1052450	usd
	clcn	Increase In Cash From Acquisition Of Subsidiary IncreaseInCashFromAcquisitionOfSubsidiary	70361	usd
CY2019Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.06	pure
CY2019Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1000000	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	2296	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	3943	usd
CY2022Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	104564	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	52284	shares
	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	Each holder of Series A Preferred Stock shall vote with holders of the Common Stock upon any matter submitted to a vote of shareholders, in which event it shall have the number of votes equal to the number of shares of Common Stock into which such share of Series A Preferred Stock would be convertible on the record date for the vote or consent of shareholders. Each holder of Series A Preferred Stock shall also be entitled to one vote per share on each submitted to a class vote of the holders of Series A Preferred Stock.
CY2022Q2	clcn	Reorganization Reorganization	1720867	usd
CY2022Q1	clcn	Shares Issued For Commitment Fees SharesIssuedForCommitmentFees	4000000	shares
CY2022Q1	clcn	Shares Issued For Commitment Fees Value SharesIssuedForCommitmentFeesValue	316324	usd
CY2022Q1	clcn	Shares Issued For Promissory Note Value SharesIssuedForPromissoryNoteValue	750000	usd
CY2022Q2	clcn	Note Issued For Cancellation Of Common Stock NoteIssuedForCancellationOfCommonStock	500000	shares
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
CY2022Q1	clcn	Convertible Preferred Stock ConvertiblePreferredStock	1720867	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	70361	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	100000	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	6600	usd
CY2022Q1	clcn	Goodwills Goodwills	1557106	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-04-20
	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.15	pure
	clcn	Note Issued For Cancellation Of Common Stock NoteIssuedForCancellationOfCommonStock	500000	shares
CY2022Q2	clcn	Note Issued For Cancellation Of Common Stock NoteIssuedForCancellationOfCommonStock	500000	shares
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	126406	usd
	us-gaap	Depreciation Depreciation	4645	usd
	clcn	Mandatory Conversion Right Description MandatoryConversionRightDescription	The Company has the right to convert each share of Series A Preferred Stock into 33.94971 shares of Common Stock at any time that there are less than 200,000 shares of Series A Preferred Stock outstanding.
	clcn	Stockbased Compensation Expense StockbasedCompensationExpense	288461	usd
	clcn	Stockbased Compensation Expense StockbasedCompensationExpense	230770	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	52284	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	104564	usd
	clcn	Stock Issued During Period Share Conversion Of Convertible Securities StockIssuedDuringPeriodShareConversionOfConvertibleSecurities	129809	shares
	clcn	Stock Issued For Conversion Of Debt Value StockIssuedForConversionOfDebtValue	288458	usd
	clcn	Stock Issued During Period Share Stock Options Exercised StockIssuedDuringPeriodShareStockOptionsExercised	112500	shares
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	300000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2022Q1	clcn	Shares Issued For Promissory Note Value SharesIssuedForPromissoryNoteValue	750000	usd
CY2022Q1	clcn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceNumber	1000000	shares
CY2022Q1	clcn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceInPeriodWeightedAverageGrantDateFairValue	0.30
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	28372	usd
CY2022Q2	clcn	Shares Issued For Promissory Note Value SharesIssuedForPromissoryNoteValue	250000	usd
	clcn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceNumber	125000	shares
	clcn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceInPeriodWeightedAverageGrantDateFairValue	0.30
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7912	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.30
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q1	clcn	Reorganizations Shares ReorganizationsShares	1882793	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7912	usd
	us-gaap	Interest Expense Other InterestExpenseOther	2000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	207	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7704	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	242296	usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	28372	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	2000000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	4833	usd

Files In Submission

Name	View Source	Status
0001731122-22-001512-index-headers.html	Edgar Link	pending
0001731122-22-001512-index.html	Edgar Link	pending
0001731122-22-001512.txt	Edgar Link	pending
0001731122-22-001512-xbrl.zip	Edgar Link	pending
clcn-20220630.xsd	Edgar Link	pending
e4032_10q.htm	Edgar Link	pending
e4032_ex31-1.htm	Edgar Link	pending
e4032_ex31-2.htm	Edgar Link	pending
e4032_ex32-1.htm	Edgar Link	pending
e4032_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
clcn-20220630_lab.xml	Edgar Link	unprocessable
clcn-20220630_def.xml	Edgar Link	unprocessable
clcn-20220630_pre.xml	Edgar Link	unprocessable
clcn-20220630_cal.xml	Edgar Link	unprocessable
e4032_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DWAY
Driveitaway Holdings, Inc. Stock $dway

2022 Q2 Form 10-Q Financial Statement

#000173112222001512 Filed on September 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DWAY Driveitaway Holdings, Inc. Stock $dway

2022 Q2 Form 10-Q Financial Statement

#000173112222001512 Filed on September 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DWAY
Driveitaway Holdings, Inc. Stock $dway